Lighthouse Investment Partners LLC trimmed its holdings in shares of LivaNova PLC (NASDAQ:LIVN - Free Report) by 23.9% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 41,000 shares of the company's stock after selling 12,876 shares during the period. Lighthouse Investment Partners LLC owned 0.08% of LivaNova worth $2,248,000 as of its most recent SEC filing.
A number of other large investors also recently modified their holdings of LIVN. Point72 Asset Management L.P. grew its position in shares of LivaNova by 204.3% during the 2nd quarter. Point72 Asset Management L.P. now owns 1,285,636 shares of the company's stock valued at $70,479,000 after buying an additional 863,157 shares during the last quarter. First Light Asset Management LLC raised its position in shares of LivaNova by 591.1% during the 2nd quarter. First Light Asset Management LLC now owns 710,390 shares of the company's stock worth $38,944,000 after purchasing an additional 607,598 shares during the period. Norges Bank bought a new stake in shares of LivaNova in the 4th quarter worth approximately $26,064,000. Great Lakes Advisors LLC bought a new stake in shares of LivaNova in the 2nd quarter worth approximately $16,614,000. Finally, Mesirow Institutional Investment Management Inc. bought a new position in LivaNova during the 1st quarter worth $13,816,000. 97.64% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
LIVN has been the topic of several recent research reports. Needham & Company LLC lifted their price objective on shares of LivaNova from $72.00 to $75.00 and gave the company a "buy" rating in a research report on Wednesday, July 31st. Robert W. Baird upgraded LivaNova from a "neutral" rating to an "outperform" rating and boosted their price objective for the stock from $55.00 to $66.00 in a research report on Tuesday, September 17th. Stifel Nicolaus lifted their target price on LivaNova from $70.00 to $72.00 and gave the company a "buy" rating in a research note on Thursday, July 25th. Finally, Baird R W raised LivaNova from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, September 17th. One equities research analyst has rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, LivaNova presently has an average rating of "Buy" and an average price target of $70.80.
Read Our Latest Research Report on LIVN
LivaNova Price Performance
LIVN stock traded up $0.21 on Friday, hitting $52.52. 379,996 shares of the company's stock traded hands, compared to its average volume of 647,505. The stock has a market cap of $2.84 billion, a price-to-earnings ratio of -87.53 and a beta of 1.00. LivaNova PLC has a 1-year low of $42.75 and a 1-year high of $64.47. The company has a current ratio of 3.45, a quick ratio of 2.94 and a debt-to-equity ratio of 0.49. The stock has a fifty day moving average of $48.71 and a 200-day moving average of $53.32.
LivaNova (NASDAQ:LIVN - Get Free Report) last issued its earnings results on Wednesday, July 31st. The company reported $0.81 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.66 by $0.15. LivaNova had a negative net margin of 1.37% and a positive return on equity of 13.77%. The company had revenue of $318.60 million during the quarter, compared to analyst estimates of $305.05 million. On average, analysts forecast that LivaNova PLC will post 2.58 EPS for the current fiscal year.
About LivaNova
(
Free Report)
LivaNova PLC, a medical device company, designs, develops, manufactures, and sells therapeutic solutions worldwide. The company operates through Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support segments. The Cardiopulmonary segment develops, produces, and sells cardiopulmonary products, including oxygenators, heart-lung machines, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related products.
Recommended Stories
Before you consider LivaNova, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and LivaNova wasn't on the list.
While LivaNova currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
